Square Pharmaceuticals Kenya EPZ Ltd, a 100 per cent subsidiary of Square Pharmaceuticals Ltd Bangladesh, on Monday started the construction work of its state-of-the-art pharmaceutical manufacturing plant through a groundbreaking ceremony in Nairobi of Kenya, said a news release.
SPL will be the 1st Bangladeshi pharmaceutical manufacturer to build its own plant outside Bangladesh.
Cabinet secretary of the Ministry of Industry, Trade and Cooperatives Adan Mohamed of Kenya, high commissioner of Bangladesh to Kenya Abul Kalam Mohammad Humayun Kabir and Square Pharmaceuticals managing director Tapan Chowdhury joined with other dignitaries from Kenya EPZ, World Bank, IFC, Standard Chartered Bank to celebrate the groundbreaking ceremony of Square Pharmaceuticals Kenya EPZ Ltd.
Square Pharmaceuticals Kenya EPZ Limited comes with world class technology of pharmaceuticals manufacturing, quality control and state-of-the-art machineries in Kenya to fill the unmet demand of medicines in EAC market (Kenya, Tanzania, Rwanda, Burundi, Uganda and South Sudan). Company’s investment in the sector will be $25 million at the first phase, the release added.
The manufacturing plant will be capable of manufacturing 2 billion tablets and capsules and 60 million bottles of liquid formulations. Products of the plant will be WHO pre-qualified and will supply throughout the Africa in long run. Commercial production is expected from first quarter of 2020.
Want stories like this in your inbox?
Sign up to exclusive daily email
More Stories from Trade & Commerce